Inhibition of IL-13-induced periostin in airway epithelium attenuates cellular protein expression of MUC5AC

Respirology

Volumn 22, Issue 1, 2017, Pages 93-100

  Suzaki, Isao ^a,b   Kawano, Shuichi ^a   Komiya, Kosaku ^a   Tanabe, Tsuyoshi ^a   Akaba, Tomohiro ^a   Asano, Kazuhito ^b   Suzaki, Harumi ^c   Izuhara, Kenji ^d   Rubin, Bruce K ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SHOWA UNIVERSITY   (Japan)

^c Tokyo General Hospital   (Japan)

^d SAGA UNIVERSITY   (Japan)

Author keywords

goblet cells; interleukin 13; MUC5AC; mucin; periostin

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; INTERLEUKIN 13; LEFLUNOMIDE; MUCIN 5AC; STAT6 PROTEIN; TRANSCRIPTION FACTOR RUNX2; CELL ADHESION MOLECULE; MUC5AC PROTEIN, HUMAN; MUCIN; POSTN PROTEIN, HUMAN; STAT6 PROTEIN, HUMAN;

ARTICLE; CELL STRUCTURE; CILIATED EPITHELIUM CELL; CONTROLLED STUDY; GOBLET CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SECRETION; PROTEIN SYNTHESIS INHIBITION; RESPIRATORY EPITHELIUM; ASTHMA; CELL CULTURE; EPITHELIUM CELL; METABOLISM; PHYSIOLOGY; RESPIRATORY MUCOSA; SECRETION (PROCESS); SIGNAL TRANSDUCTION;

ASTHMA; CELL ADHESION MOLECULES; CELLS, CULTURED; EPITHELIAL CELLS; GOBLET CELLS; HUMANS; INTERLEUKIN-13; MUCIN 5AC; MUCINS; RESPIRATORY MUCOSA; SIGNAL TRANSDUCTION; STAT6 TRANSCRIPTION FACTOR;

EID: 84983409150     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12873     Document Type: Article

References (39)

1. Cohn L, Tepper JS, Bottomly K. IL-4-independent induction of airway hyperresponsiveness by Th2, but not Th1, cells. J. Immunol. 1998; 161: 3813–6.
2. Vargaftig BB, Singer M. Leukotrienes, IL-13, and chemokines cooperate to induce BHR and mucus in allergic mouse lungs. Am. J. Physiol. Lung Cell Mol. Physiol. 2003; 284: L260–9.
3. Hartley R, Berair R, Brightling CE. Severe asthma: novel advances in the pathogenesis and therapy. Pol. Arch. Med. Wewn. 2014; 124: 247–54.
4. Wills-Karp M. Interleukin-13 in asthma pathogenesis. Curr. Allergy Asthma Rep. 2004; 4: 123–31.
5. Oh CK, Geba GP, Molfino N. Investigational therapeutics targeting the IL-4/IL-13/STAT-6 pathway for the treatment of asthma. Eur. Respir. Rev. 2010; 19: 46–54.
6. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, Donaldson DD. Interleukin-13: central mediator of allergic asthma. Science 1998; 282: 2258–61.
7. Izuhara K, Arima K, Ohta S, Suzuki S, Inamitsu M, Yamamoto K. Periostin in allergic inflammation. Allergol. Int. 2014; 63: 143–51.
8. Ohta N, Ishida A, Kurakami K, Suzuki Y, Kakehata S, Ono J, Ikeda H, Okubo K, Izuhara K. Expressions and roles of periostin in otolaryngological diseases. Allergol. Int. 2014; 63: 171–80.
9. Conway SJ, Izuhara K, Kudo Y, Litvin J, Markwald R, Ouyang G, Arron JR, Holweg CT, Kudo A. The role of periostin in tissue remodeling across health and disease. Cell. Mol. Life Sci. 2014; 71: 1279–88.
10. Li W, Gao P, Zhi Y, Xu W, Wu Y, Yin J, Zhang J. Periostin: its role in asthma and its potential as a diagnostic or therapeutic target. Respir. Res. 2015; 16: 57–66.
11. Takayama G, Arima K, Kanaji T, Toda S, Tanaka H, Shoji S, McKenzie AN, Nagai H, Hotokebuchi T, Izuhara K. Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. J. Allergy Clin. Immunol. 2006; 118: 98–104.
12. Sidhu SS, Yuan S, Innes AL, Kerr S, Woodruff PG, Hou L, Muller SJ, Fahy JV. Roles of epithelial cell-derived periostin in TGF-beta activation, collagen production, and collagen gel elasticity in asthma. Proc. Natl. Acad. Sci. U. S. A. 2010; 107: 14170–5.
13. Mouthuy J, Viart S, Ladjemi MZ, Detry B, Henket M, Bachert C, Louis R, Pilette C. Mite allergen-specific IgE is detectable in bronchial secretions of patients with nonatopic asthma and correlates with mucosal expression of periostin. J. Allergy Clin. Immunol. 2015; 136: 1685–8.e2.
14. Matsumoto H. Serum periostin: a novel biomarker for asthma management. Allergol. Int. 2014; 63: 153–60.
15. Saha SK, Berry MA, Parker D, Siddiqui S, Morgan A, May R, Monk P, Bradding P, Wardlaw AJ, Pavord ID et al. Increased sputum and bronchial biopsy IL-13 expression in severe asthma. J. Allergy Clin. Immunol. 2008; 121: 685–91.
16. Hoshino M, Ohtawa J, Akitsu K. Effect of treatment with inhaled corticosteroid on serum periostin levels in asthma. Respirology 2016; 21: 297–303.
17. Tanabe T, Rubin BK. Airway goblet cells secrete pro-inflammatory cytokines, chemokines and growth factors. Chest 2016; 149: 714–20.
18. Naik PK, Bozyk PD, Bentley JK, Popova AP, Birch CM, Wilke CA, Fry CD, White ES, Sisson TH, Tayob N et al. Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 2012; 303: L1046–56.
19. Orecchia P, Conte R, Balza E, Castellani P, Borsi L, Zardi L, Mingari MC, Carnemolla B. Identification of a novel cell binding site of periostin involved in tumour growth. Eur. J. Cancer 2011; 47: 2221–9.
20. Bentley JK, Chen Q, Hong JY, Popova AP, Lei J, Moore BB, Hershenson MB. Periostin is required for maximal airways inflammation and hyperresponsiveness in mice. J. Allergy Clin. Immunol. 2014; 134: 1433–42.
21. Tanabe T, Kanoh S, Tsushima K, Yamazaki Y, Kubo K, Rubin BK. Clarithromycin inhibits interleukin-13-induced goblet cell hyperplasia in human airway cells. Am. J. Respir. Cell Mol. Biol. 2011; 45: 1075–83.
22. Kanoh S, Tanabe T, Rubin BK. Dapsone inhibits IL-8 secretion from human bronchial epithelial cells stimulated with lipopolysaccharide and resolves airway inflammation in the ferret. Chest 2011; 140: 980–90.
23. Kanoh S, Tanabe T, Rubin BK. IL-13-induced MUC5AC production and goblet cell differentiation is steroid resistant in human airway cells. Clin. Exp. Allergy 2011; 41: 1747–56.
24. Tanabe T, Shimokawaji T, Kanoh S, Rubin BK. Secretory phospholipases A2 are secreted from ciliated cells and increase mucin and eicosanoid secretion from goblet cells. Chest 2015; 147: 1599–609.
25. Tanabe T, Shimokawaji T, Kanoh S, Rubin BK. IL-33 stimulates CXCL8/IL-8 secretion in goblet cells but not normally differentiated airway cells. Clin. Exp. Allergy 2014; 44: 540–52.
26. Jia G, Erickson RW, Choy DF, Mosesova S, Wu LC, Solberg OD, Shikotra A, Carter R, Audusseau S, Hamid Q et al. Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients. J. Allergy Clin. Immunol. 2012; 130: 647–54.e10.
27. Hanania NA, Noonan M, Corren J, Korenblat P, Zheng Y, Fischer SK, Cheu M, Putnam WS, Murray E, Scheerens H et al. Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies. Thorax 2015; 70: 748–56.
28. Tanabe T, Fujimoto K, Yasuo M, Tsushima K, Yoshida K, Ise H, Yamaya M. Modulation of mucus production by interleukin-13 receptor alpha2 in the human airway epithelium. Clin. Exp. Allergy 2008; 38: 122–34.
29. Parker JC, Thavagnanam S, Skibinski G, Lyons J, Bell J, Heaney LG, Shields MD. Chronic IL9 and IL-13 exposure leads to an altered differentiation of ciliated cells in a well-differentiated paediatric bronchial epithelial cell model. PLoS One 2013; 8: e61023.
30. Izuhara K, Arima K, Kanaji S, Ohta S, Kanaji T. IL-13: a promising therapeutic target for bronchial asthma. Curr. Med. Chem. 2006; 13: 2291–8.
31. Walford HH, Doherty TA. STAT6 and lung inflammation. JAKSTAT 2013; 2: e25301–11.
32. Lee PJ, Zhang X, Shan P, Ma B, Lee CG, Homer RJ, Zhu Z, Rincon M, Mossman BT, Elias JA. ERK1/2 mitogen-activated protein kinase selectively mediates IL-13-induced lung inflammation and remodeling in vivo. J. Clin. Invest. 2006; 116: 163–73.
33. Atherton HC, Jones G, Danahay H. IL-13-induced changes in the goblet cell density of human bronchial epithelial cell cultures: MAP kinase and phosphatidylinositol 3-kinase regulation. Am. J. Physiol. Lung Cell. Mol. Physiol. 2003; 285: L730–9.
34. Masuoka M, Shiraishi H, Ohta S, Suzuki S, Arima K, Aoki S, Toda S, Inagaki N, Kurihara Y, Hayashida S et al. Periostin promotes chronic allergic inflammation in response to Th2 cytokines. J. Clin. Invest. 2012; 122: 2590–600.
35. Li P, Oparil S, Feng W, Chen YF. Hypoxia-responsive growth factors upregulate periostin and osteopontin expression via distinct signaling pathways in rat pulmonary arterial smooth muscle cells. J. Appl. Physiol. 2004; 97: 1550–8.
36. Sidebotham HJ, Roche WR. Asthma deaths; persistent and preventable mortality. Histopathology 2003; 43: 105–17.
37. Kuyper LM, Pare PD, Hogg JC, Lambert RK, Ionescu D, Woods R, Bai TR. Characterization of airway plugging in fatal asthma. Am. J. Med. 2003; 115: 6–11.
38. Ordonez CL, Khashayar R, Wong HH, Ferrando R, Wu R, Hyde DM, Hotchkiss JA, Zhang Y, Novikov A, Dolganov G et al. Mild and moderate asthma is associated with airway goblet cell hyperplasia and abnormalities in mucin gene expression. Am. J. Respir. Crit. Care Med. 2001; 163: 517–23.
39. Young HW, Williams OW, Chandra D, Bellinghausen LK, Perez G, Suarez A, Tuvim MJ, Roy MG, Alexander SN, Moghaddam SJ et al. Central role of Muc5ac expression in mucous metaplasia and its regulation by conserved 5' elements. Am. J. Respir. Cell Mol. Biol. 2007; 37: 273–90.